The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ... Radiology 295 (2), 328-338, 2020 | 2840 | 2020 |
Introduction to radiomics ME Mayerhoefer, A Materka, G Langs, I Häggström, P Szczypiński, ... Journal of Nuclear Medicine 61 (4), 488-495, 2020 | 1194 | 2020 |
Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1110 | 2017 |
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ... Insights into imaging 3, 573-589, 2012 | 952 | 2012 |
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. GJ Cook, S Houston, R Rubens, MN Maisey, I Fogelman Journal of clinical Oncology 16 (10), 3375-3379, 1998 | 692 | 1998 |
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis S Chicklore, V Goh, M Siddique, A Roy, PK Marsden, GJR Cook European journal of nuclear medicine and molecular imaging 40, 133-140, 2013 | 556 | 2013 |
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013 | 523 | 2013 |
Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? GJR Cook, C Yip, M Siddique, V Goh, S Chicklore, A Roy, P Marsden, ... Journal of nuclear medicine 54 (1), 19-26, 2013 | 463 | 2013 |
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation GJR Cook, I Fogelman, MN Maisey Seminars in nuclear medicine 26 (4), 308-314, 1996 | 441 | 1996 |
Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate GM Blake, SJ Park-Holohan, GJR Cook, I Fogelman Seminars in nuclear medicine 31 (1), 28-49, 2001 | 350 | 2001 |
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging GJR Cook, EA Wegner, I Fogelman Seminars in nuclear medicine 34 (2), 122-133, 2004 | 326 | 2004 |
Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine GJR Cook, MN Maisey, I Fogelman European journal of nuclear medicine 26, 1363-1378, 1999 | 311 | 1999 |
Positron emission tomography and bone metastases I Fogelman, G Cook, O Israel, H Van der Wall Seminars in nuclear medicine 35 (2), 135-142, 2005 | 309 | 2005 |
Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome C Yip, C Dinkel, A Mahajan, M Siddique, GJR Cook, V Goh Insights into imaging 6, 489-497, 2015 | 260 | 2015 |
Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer C Yip, V Goh, A Davies, J Gossage, R Mitchell-Hay, O Hynes, N Maisey, ... European radiology 24, 998-1005, 2014 | 229 | 2014 |
Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma SC Rankin, H Taylor, GJR Cook, R Mason Clinical radiology 53 (9), 659-665, 1998 | 215 | 1998 |
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. S Maurea, C Mainolfi, L Bazzicalupo, MR Panico, C Imparato, B Alfano, ... AJR. American journal of roentgenology 173 (1), 25-29, 1999 | 205 | 1999 |
Predicting response to neoadjuvant chemotherapy with PET imaging using convolutional neural networks PP Ypsilantis, M Siddique, HM Sohn, A Davies, G Cook, V Goh, ... PloS one 10 (9), e0137036, 2015 | 201 | 2015 |
The role of positron emission tomography in the management of bone metastases GJR Cook, I Fogelman Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 187 | 2000 |
Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of 18F-FDG Uptake at PET—Association with Treatment Response and Prognosis GJR Cook, ME O’Brien, M Siddique, S Chicklore, HY Loi, B Sharma, ... Radiology 276 (3), 883-893, 2015 | 182 | 2015 |